Oral Cancer Screening and Testing
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB032 alerts
Get alerted when Policy RPLAB032 changes without checking for updates manually.
Monitor payer policy activity
Reimbursement for laboratory testing used to establish HPV tumor status in certain head and neck cancers and for tests intended to screen for, detect, or diagnose oral cancer, subject to plan documents and provider contracts.
The policy clarified that mRNA CancerDetect and OmniPathology oropharyngeal HPV PCR testing are not reimbursable.
Procedure code 0296U was added to the policy's listed procedure codes.
Procedure codes 81599, 82397, 88341, and 88342 were removed from the policy.
The policy references were revised.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.